ABDI IBRAHIM
ACROSS THE GLOBE

Growing Strength in the International Arena

Abdi İbrahim consolidates its position in the international arena with exports to over 70 countries. The company grows in a sustainable manner by employing various strategic business models under its own brand and those of its customers in its operating regions.

The company maintains its growth in Kazakhstan, Algeria, Iraq, Georgia, Azerbaijan, Albania, England, Bosnia and Herzegovina, Portugal, Qatar, Tunisia, Saudi Arabia and the United Arab Emirates with Abdi İbrahim branded products and its own sales and marketing organizations. With an overseas field and office staff of 650 in 17 overseas countries, Abdi İbrahim benefits from a diverse portfolio of Abdi İbrahim and customer-branded products in several markets across the globe, including Europe and Canada. With licensed sales across the globe, the company’s export figures are also on a continuous trend upwards.

Developing Markets

In addition to employing its own sales-marketing teams in several countries, Abdi İbrahim operates through local distributors in various developing markets. Local distributors bring Abdi İbrahim products to patients in many regions, further increasing the company’s brand recognition with new products. Meanwhile, Abdi İbrahim also keeps a close eye on pharmaceutical industry dynamics in its markets to seize new opportunities as they present themselves.

In parallel with its 2025 targets and its goal of becoming a global player, Abdi İbrahim has focused its expansion strategy on developing markets and determines target markets accordingly. In this context, Abdi İbrahim develops new business models for countries where it already has operations but no in-house sales & marketing organization, as well as market entry strategies for new markets. With a new organization and business models, Abdi İbrahim aims to position itself as a strong player especially in the GCC, CIS, Balkans and Asia-Pacific and Latin America.

Developed Markets

As the largest player in the Turkish pharmaceutical industry, Abdi İbrahim exports its products to 70 countries through out licensing in developed markets, distributors and joint product development with leading firms. Furthermore, Abdi İbrahim markets European products via its Portuguese subsidiary Abdi Farma. Abdi İbrahim engages in out licensing operations in Europe, Canada and Australia, enhancing its market presence with European-standard products developed and produced in its EU GMP certified production facility in Istanbul. In addition to out licensing, Abdi İbrahim also sells Abdi Farma licensed products in various European countries via distributors. The company also continues joint product development with various leading pharmaceutical companies.

Healing more lives with each passing day with exports to over 70 countries...

Organizational structuring in 18 countries

Export to more than 70 countries